Coffee Consumption and Prostate Cancer Risk: A Meta-Analysis of Cohort Studies

REFERENCES

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al.: Global cancer statistics. CA Cancer J Clin 61, 69–90, 2011. doi:10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Wilson KM, Giovannucci EL, and Mucci LA: Lifestyle and dietary factors in the prevention of lethal prostate cancer. Asian J Androl 14, 365–74, 2012. doi:10.1038/aja.2011.142
   PubMed Web of Science ®Google Scholar
• Yu H, Harris RE, Gao YT, Gao R, and Wynder EL: Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol 20, 76–81, 1991.
   PubMed Web of Science ®Google Scholar
• Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, et al.: Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40, 1155–1163, 2002.
   PubMed Web of Science ®Google Scholar
• Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Strom EC, et al.: Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134, 562–567, 2004.
   PubMed Web of Science ®Google Scholar
• Gomez-Ruiz JA, Leake DS, and Ames JM: In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem 55, 6962–9, 2007. doi:10.1021/jf0710985
   PubMed Web of Science ®Google Scholar
• Cardenas C, Quesada AR, and Medina MA: Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene. PLoS One 6, e23407, 2011. doi:10.1371/journal.pone.0023407
   Web of Science ®Google Scholar
• Park CH, Myung SK, Kim TY, Seo HG, Jeon YJ, et al.: Coffee consumption and risk of prostate cancer: a meta-analysis of epidemiological studies. BJU Int 106, 762–769, 2010. doi:10.1111/j.1464-410X.2010.09493.x
   PubMed Web of Science ®Google Scholar
• Yu X, Bao Z, Zou J, and Dong J: Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 11, 96, 2011. doi:10.1186/1471-2407-11-96
   Web of Science ®Google Scholar
• Nilsson LM, Johansson I, Lenner P, Lindahl B, and Van Guelpen B: Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 21, 1533–1544, 2010. doi:10.1007/s10552-010-9582-x
   PubMed Web of Science ®Google Scholar
• Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM, et al.: Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst 103, 876–84, 2011. doi:10.1093/jnci/djr151
   PubMed Web of Science ®Google Scholar
• Shafique K, McLoone P, Qureshi K, Leung H, Hart C, et al.: Coffee consumption and prostate cancer risk: further evidence for inverse relationship. Nutr J 11, 42, 2012. doi:10.1186/1475-2891-11-42
   PubMed Web of Science ®Google Scholar
• Bosire C, Stampfer MJ, Subar AF, Wilson KM, Park Y, et al.: Coffee consumption and the risk of overall and fatal prostate cancer in the NIH-AARP Diet and Health Study. Cancer Causes Control 24, 1527–1534, 2013. doi:10.1007/s10552-013-0229-6
   PubMed Web of Science ®Google Scholar
• Discacciati A, Orsini N, Andersson SO, Andren O, Johansson JE, et al.: Coffee consumption and risk of localized, advanced and fatal prostate cancer: a population-based prospective study. Ann Oncol 24, 1912–1918, 2013. doi:10.1093/annonc/mdt105
   PubMed Web of Science ®Google Scholar
• Li Q, Kakizaki M, Sugawara Y, Tomata Y, Watanabe T, et al.: Coffee consumption and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer 108, 2381–2389, 2013. doi:10.1038/bjc.2013.238
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al.: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008–2012, 2000.
   PubMed Web of Science ®Google Scholar
• Severson RK, Nomura AM, Grove JS, and Stemmermann GN: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49, 1857–1860, 1989.
   PubMed Web of Science ®Google Scholar
• Ellison LF: Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study. Eur J Cancer Prev 9, 125–130, 2000.
   PubMed Web of Science ®Google Scholar
• Allen NE, Sauvaget C, Roddam AW, Appleby P, Nagano J, et al.: A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control 15, 911–920, 2004. doi:10.1007/s10552-004-1683-y
   PubMed Web of Science ®Google Scholar
• Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539–1558, 2002. doi:10.1002/sim.1186
   PubMed Web of Science ®Google Scholar
• Hedges LV and Pigott TD: The power of statistical tests for moderators in meta-analysis. Psychol Methods 9, 426–445, 2004. doi:10.1037/1082-989x.9.4.426
   PubMed Web of Science ®Google Scholar
• Begg CB and Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088–1101, 1994.
   PubMed Web of Science ®Google Scholar
• Egger M and Smith GD: Bias in location and selection of studies. BMJ 316, 61–66, 1998.
   PubMed Web of Science ®Google Scholar
• Orsini N, Li R, Wolk A, Khudyakov P, and Spiegelman D: Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175, 66–73, 2012. doi:10.1093/aje/kwr265
   PubMed Web of Science ®Google Scholar
• Orsini NBR and Greenland S: Generalized least squares for trend estimation of summarized dose-respose data. Stata J 6, 40–57, 2006.
   Web of Science ®Google Scholar
• Jackson D, White IR, and Thompson SG: Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med 29, 1282–1297, 2010. doi:10.1002/sim.3602
   PubMed Web of Science ®Google Scholar
• Greenland S and Longnecker MP: Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135, 1301–1309, 1992.
   PubMed Web of Science ®Google Scholar
• Jacobsen BK, Bjelke E, Kvale G, and Heuch I: Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 76, 823–831, 1986.
   PubMed Web of Science ®Google Scholar
• Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, et al.: Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res 50, 6836–6840, 1990.
   PubMed Web of Science ®Google Scholar
• Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, and Hirohata T: Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 5, 276–282, 1994.
   PubMed Web of Science ®Google Scholar
• Stensvold I and Jacobsen BK: Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5, 401–408, 1994.
   PubMed Web of Science ®Google Scholar
• Sang LX, Chang B, Li XH, and Jiang M: Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterol 13, 34, 2013. doi:10.1186/1471-230x-13-34
   Web of Science ®Google Scholar
• Dong J, Zou J, and Yu XF: Coffee drinking and pancreatic cancer risk: a meta-analysis of cohort studies. World J Gastroenterol 17, 1204–1210, 2011. doi:10.3748/wjg.v17.i9.1204
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, et al.: Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87, 1767–1776, 1995.
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, and Willett WC: Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6, 557–563, 1997.
   PubMed Web of Science ®Google Scholar
• Platz EA, Rimm EB, Willett WC, Kantoff PW, and Giovannucci E: Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst 92, 2009–2017, 2000.
   PubMed Web of Science ®Google Scholar
• Willett WC, Stampfer MJ, Manson JE, Colditz GA, Rosner BA, et al.: Coffee consumption and coronary heart disease in women. A ten-year follow-up. JAMA 275, 458–462, 1996.
   PubMed Web of Science ®Google Scholar
• Leviton A and Cowan L: A review of the literature relating caffeine consumption by women to their risk of reproductive hazards. Food Chem Toxicol 40, 1271–310, 2002.
   PubMed Web of Science ®Google Scholar
• Miura Y, Ono K, Okauchi R, and Yagasaki K: Inhibitory effect of coffee on hepatoma proliferation and invasion in culture and on tumor growth, metastasis and abnormal lipoprotein profiles in hepatoma-bearing rats. J Nutr Sci Vitaminol (Tokyo) 50, 38–44, 2004.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, He Z, Ma WY, Schmid PC, Bode AM, et al.: Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells. Cancer Res 64, 3344–3349, 2004.
   PubMed Web of Science ®Google Scholar
• Lee WJ and Zhu BT: Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27, 269–277, 2006. doi:10.1093/carcin/bgi206
   PubMed Web of Science ®Google Scholar
• Asaad NA, Zeng ZC, Guan J, Thacker J, and Iliakis G: Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants. Oncogene 19, 5788–5800, 2000. doi:10.1038/sj.onc.1203953
   PubMed Web of Science ®Google Scholar
• Joerges C, Kuntze I, and Herzinger T: Induction of a caffeine-sensitive S-phase cell cycle checkpoint by psoralen plus ultraviolet A radiation. Oncogene 22, 6119–6128, 2003. doi:10.1038/sj.onc.1206613
   PubMed Web of Science ®Google Scholar
• Saiki S, Sasazawa Y, Imamichi Y, Kawajiri S, Fujimaki T, et al.: Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy 7, 176–187, 2011.
   PubMed Web of Science ®Google Scholar
• Feng R, Lu Y, Bowman LL, Qian Y, Castranova V, et al.: Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 280, 27888–27895, 2005. doi:10.1074/jbc.M503347200
   PubMed Web of Science ®Google Scholar